BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21352471)

  • 1. Functional analysis of microRNAs in human hepatocellular cancer stem cells.
    Meng F; Glaser SS; Francis H; DeMorrow S; Han Y; Passarini JD; Stokes A; Cleary JP; Liu X; Venter J; Kumar P; Priester S; Hubble L; Staloch D; Sharma J; Liu CG; Alpini G
    J Cell Mol Med; 2012 Jan; 16(1):160-73. PubMed ID: 21352471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
    Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
    Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
    Bai S; Nasser MW; Wang B; Hsu SH; Datta J; Kutay H; Yadav A; Nuovo G; Kumar P; Ghoshal K
    J Biol Chem; 2009 Nov; 284(46):32015-27. PubMed ID: 19726678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.
    Salvi A; Conde I; Abeni E; Arici B; Grossi I; Specchia C; Portolani N; Barlati S; De Petro G
    Mol Cancer; 2013 Dec; 12():162. PubMed ID: 24330766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
    J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Kabir TD; Ganda C; Brown RM; Beveridge DJ; Richardson KL; Chaturvedi V; Candy P; Epis M; Wintle L; Kalinowski F; Kopp C; Stuart LM; Yeoh GC; George J; Leedman PJ
    Hepatology; 2018 Jan; 67(1):216-231. PubMed ID: 28833396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
    Chen Y; Feng F; Gao X; Wang C; Sun H; Zhang C; Zeng Z; Lu Y; An L; Qu J; Wang F; Yang Y
    Curr Cancer Drug Targets; 2015; 15(3):176-87. PubMed ID: 25714700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
    Ji J; Yamashita T; Budhu A; Forgues M; Jia HL; Li C; Deng C; Wauthier E; Reid LM; Ye QH; Qin LX; Yang W; Wang HY; Tang ZY; Croce CM; Wang XW
    Hepatology; 2009 Aug; 50(2):472-80. PubMed ID: 19585654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
    Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY
    Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.
    Xu J; Lin H; Li G; Sun Y; Chen J; Shi L; Cai X; Chang C
    EBioMedicine; 2016 Oct; 12():55-67. PubMed ID: 27688096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
    Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
    Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
    Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
    J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression.
    Azumi J; Tsubota T; Sakabe T; Shiota G
    Cancer Sci; 2016 Sep; 107(9):1256-62. PubMed ID: 27384977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma.
    Zhou C; Liu J; Li Y; Liu L; Zhang X; Ma CY; Hua SC; Yang M; Yuan Q
    FEBS Lett; 2011 Jun; 585(12):1828-34. PubMed ID: 21530512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
    Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZEB1 causes the production of hsa-microRNA-99b/let-7e/microRNA-125a cluster and promotes invasion of liver cancer cells.
    Wang XF; Liu JY; Li JL; Wang FZ; Sun BL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1468-1475. PubMed ID: 30840268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.